SCHEMBL7089640

SCHEMBL7089640

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C(=O)OCc2ccccc2)cc1C(=N)N)S(=O)(=O)c1cccc2ccccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
PARP1 P09874 1/20 0.35
THRB P10828 1/20 0.34
SRD5A1 P18405 1/20 0.34
SRD5A2 P31213 1/20 0.34
RORC P51449 1/20 0.34
NR3C1 P04150 2/20 0.33
F2 P00734 5/20 0.33
ALDH1A1 P00352 3/20 0.33
HPGD P15428 2/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
AVPR2 P30518 1/20 0.32
POLB P06746 1/20 0.32
F10 P00742 2/20 0.32
ITGB3 P05106 2/20 0.32
ITGA2B P08514 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6978636 0.95 PDK1 (0.36) PDK1PDK2PDK3PDK4PARP1
SCHEMBL6982379 0.95 THRB (0.35) PDK1PDK2PDK3PDK4PARP1
SCHEMBL7085095 0.92 ALDH1A1 (0.36) PDK1PDK2PDK3PDK4PARP1
SCHEMBL7088164 0.90 THRB (0.36) PDK1PDK2PDK3PDK4PARP1
SCHEMBL6979712 0.90 F2 (0.35) PARP1THRBSRD5A1SRD5A2RORC
SCHEMBL6984290 0.87 F10 (0.35) PARP1THRBSRD5A1SRD5A2RORC
Hydrochloric Acid SCHEMBL6979622 0.86 F2 (0.39) PDK1PDK2PDK3PDK4PARP1
SCHEMBL6984481 0.85 F2 (0.41) PDK1PDK2PDK3PDK4F2
SCHEMBL6979175 0.85 USP2 (0.39) PDK1PDK2PDK3PDK4NR3C1
SCHEMBL7089638 0.84 PARP1 (0.36) PDK1PDK2PDK3PDK4PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP disclosed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed
EP-0991624-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT Boehringer Ingelheim Pharma KG (DE) 2000-04-12 EP disclosed
WO-1999000371-A1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-01-07 WO disclosed